• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

ImmunoCellular Therapeutics Ltd

+ Add to Watchlist

IMUC:US

0.9800 USD 0.0100 1.01%

As of 18:40:03 ET on 07/28/2014.

Snapshot for ImmunoCellular Therapeutics Ltd (IMUC)

Open: 0.9717 Day's Range: 0.9700 - 1.0000 Volume: 234,012
Previous Close: 0.9900 52wk Range: 0.6515 - 4.0000 1-Yr Rtn: -65.00%

Stock Chart for IMUC

No chart data available.
  • IMUC:US 0.9800
  • 1D
  • 1M
  • 1Y
0.9900
Interactive IMUC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMUC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1220
Est. EPS (USD) (12/2014) -0.2200
Est. PEG Ratio -
Market Cap (M USD) 56.76
Shares Outstanding (M) 57.92
30 Day Average Volume 552,100
Price/Book (mrq) 2.4010
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMUC

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IMUC

ImmunoCellular Therapeutics, Ltd. is a development stage company that seeks to develop imaging devices with medical diagnostic applications.

John S YuChairman/Chief Scientific Ofcr/SecyAndrew W GengosPresident/CEO
David E FractorVP:Finance/CFO/TreasurerAnthony J Gringeri "Tony"Senior VP:Strategic Resources
More Company Profile & Key Executives for IMUC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil